Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab.
Rodier C, Kanagaratnam L, Morland D, Herbin A, Durand A, Chauchet A, Choquet S, Colin P, Casasnovas RO, Deconinck E, Godard F, Delmer A, Rossi C, Durot E.
Rodier C, et al. Among authors: godard f.
Hemasphere. 2023 Apr 26;7(5):e861. doi: 10.1097/HS9.0000000000000861. eCollection 2023 May.
Hemasphere. 2023.
PMID: 37125257
Free PMC article.